Details for New Drug Application (NDA): 205054
✉ Email this page to a colleague
The generic ingredient in LEUPROLIDE ACETATE FOR DEPOT SUSPENSION is leuprolide acetate. There are twenty-two drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the leuprolide acetate profile page.
Summary for 205054
Tradename: | LEUPROLIDE ACETATE FOR DEPOT SUSPENSION |
Applicant: | Invagen Pharms |
Ingredient: | leuprolide acetate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 205054
Suppliers and Packaging for NDA: 205054
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LEUPROLIDE ACETATE FOR DEPOT SUSPENSION | leuprolide acetate | FOR SUSPENSION;INTRAMUSCULAR | 205054 | NDA | CIPLA USA INC. | 69097-909 | 69097-909-50 | 1 KIT in 1 CARTON (69097-909-50) * 2 mL in 1 VIAL, SINGLE-DOSE (69097-950-32) * 2 mL in 1 SYRINGE (69097-960-31) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SUSPENSION;INTRAMUSCULAR | Strength | 22.5MG/VIAL | ||||
Approval Date: | Aug 28, 2018 | TE: | RLD: | Yes |
Expired US Patents for NDA 205054
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Invagen Pharms | LEUPROLIDE ACETATE FOR DEPOT SUSPENSION | leuprolide acetate | FOR SUSPENSION;INTRAMUSCULAR | 205054-001 | Aug 28, 2018 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription